India grants patent to Gilead’s expensive hepatitis drug, Sovaldi (Sofosbuvir)

Sovaldi (sofosbuvir) had earlier faced a thumb down on the patent application by the Controller General of Patents, Designs and Trademark but the latest ruling overturns that decision. Gilead has applied  for patent numbered 6087/DELNP/2005 claiming the active metabolites of sofosbuvir on 27th March 2005 and was refused by IPO on 13th Jan 2015, then remanded back by Hon’ble Delhi High Court […]

Nestlé’s Four-Finger Chocolate Bar Not Entitled To Trade Mark Protection

Nestle’s attempt to trademark the KitKat shape was denied in England. The British High Court ruling on Wednesday was the culmination of the long legal battle between Nestle and Cadbury over the shape of the four-fingered candy bar. Judge Richard Arnold found that the shape wasn’t distinctive enough to warrant a trademark. Arnold concluded that the shoppers weren’t likely to confuse KitKats with similarly […]

Indian office CGPDTM joins TMclass: online tool for classifying goods and services

Indian Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) joins TMclass (on 07 December 2015). This successful integration is the result of the EU-INDIA Intellectual Property Cooperation (IPC-EUI) project co-fundedby the European Union and the Office for Harmonization in the Internal Market within the framework of the International Cooperation Programme and in close collaboration with CGPDTM TMClass is an […]

Guidelines for Examination of Computer Related Inventions (CRIs) put on hold

Guidelines for Examination of Computer Related Inventions issued on 21-08-2015 (click here) are put on hold, in view of several representations received regarding interpretation and scope of section 3 (k) of the Patents Act 1970. Earlier, only software used in combination with hardware could be patented, but the revised draft guidelines allowed the patenting of software which demonstrated technical advancement, for […]

New IPR Initiatives India

Govt. of India is working to reduce the approval time of patent from the current 5-6 years to 15 months. The proposed draft amendments 2015 will reduce the granting time, for instance Expeditious examination process available when the applicant or his assignee or prospective manufacturer (licensee) has already started manufacturing of the invention in India, or has undertaken that the […]

Pfizer’s arthritis drug patent rejected in India

Pfizer’s arthritis drug Tofacitinib patent is rejected by Indian Patent Office. Indian Patent Office had rejected Pfizer’s application to patent tofacitinib in 2011, but  by the Pfizer’s Appeal, the Intellectual Property Appellate Board (IPAB) in October last year set aside an order by the patent office which rejected Pfizer’s patent for a new formula of the drug and directed it […]